Aspire Biopharma Holdings (ASBP) Amortizatization of Intangibles (2025 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Amortizatization of Intangibles came in at $1.6 million in Q1 2026, up 13530.72% year-on-year from N/an in Q1 2025, and down 73.59% on a QoQ basis from $6.0 million in Q4 2025.
Aspire Biopharma Holdings (ASBP) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 2 years of Amortizatization of Intangibles data on file, last reported at $1.6 million in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 13530.72% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $7.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at $8.0 million, up 5667.23% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $1.6 million, down from $6.0 million in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for ASBP reached as high as $6.0 million in Q4 2025 and fell as low as $11620.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Aspire Biopharma Holdings | 1.09 Mn | -733,865.14 | 5,750.00 | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 19,476.00 |
| Sep 30, 2025 | 19,476.00 |
| Mar 31, 2025 | 11,620.00 |
| Mar 31, 2025 | 11,620.00 |